Allergan and Mohawk tribe ask SCOTUS to review controversial Restasis patent licensing deal

Can tribal immunity shield a drug from patent challenge? Allergan and the Mohawk tribe want the Supreme Court to weigh in on their controversial deal aimed at doing just that for the drugmaker's blockbuster Restasis.